We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.11%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$10.9B
AUM Growth
+$354M
Cap. Flow
-$371M
Cap. Flow %
-3.39%
Top 10 Hldgs %
21.68%
Holding
2,365
New
95
Increased
251
Reduced
1,484
Closed
53

Sector Composition

Rank Sector Weight
1 Technology 20.23%
2 Financials 13.41%
3 Healthcare 12.54%
4 Consumer Discretionary 11.8%
5 Industrials 9.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQBK icon
2051
Equity Bancshares
EQBK
$1.06B
$200K ﹤0.01%
7,293
BFC icon
2052
Bank First Corp
BFC
$1.74B
$200K ﹤0.01%
2,663
PGEN icon
2053
Precigen
PGEN
$2.45B
$200K ﹤0.01%
28,961
+10,389
+56% +$87.8K
CCCC icon
2054
C4 Therapeutics
CCCC
$480M
$198K ﹤0.01%
5,348
BDTX icon
2055
Black Diamond Therapeutics
BDTX
$121M
$198K ﹤0.01%
8,148
BOLT icon
2056
Bolt Biotherapeutics
BOLT
$6.63M
$197K ﹤0.01%
+300
New +$195K
SPPI
2057
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$197K ﹤0.01%
60,440
-1,965
-3% -$7.04K
CIO
2058
DELISTED
City Office REIT
CIO
$197K ﹤0.01%
18,545
+8,395
+83% +$85.8K
NSSC icon
2059
Napco Security Technologies
NSSC
$1.39B
$197K ﹤0.01%
11,304
OPY icon
2060
Oppenheimer Holdings
OPY
$1.23B
$196K ﹤0.01%
4,905
FISI icon
2061
Financial Institutions
FISI
$825M
$196K ﹤0.01%
6,461
MOFG
2062
DELISTED
MidWestOne Financial Group
MOFG
$195K ﹤0.01%
6,292
-3,585
-36% -$102K
EAR
2063
DELISTED
Eargo, Inc. Common Stock
EAR
$195K ﹤0.01%
195
CPRX
2064
DELISTED
Catalyst Pharmaceutical
CPRX
$195K ﹤0.01%
42,220
+25,452
+152% +$101K
ARAY icon
2065
Accuray
ARAY
$33.4M
$194K ﹤0.01%
39,130
+19,003
+94% +$98K
RBNC
2066
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
$193K ﹤0.01%
6,730
-1,339
-17% -$30.7K
CMRE icon
2067
Costamare
CMRE
$1.71B
$193K ﹤0.01%
20,091
+14,686
+272% +$137K
ORGO icon
2068
Organogenesis Holdings
ORGO
$233M
$193K ﹤0.01%
+10,607
New +$144K
TRUE
2069
DELISTED
TrueCar
TRUE
$193K ﹤0.01%
40,352
+18,751
+87% +$92.9K
LORL
2070
DELISTED
Loral Space and Communications, Inc.
LORL
$193K ﹤0.01%
+5,120
New +$182K
ARLO icon
2071
Arlo Technologies
ARLO
$1.5B
$193K ﹤0.01%
30,698
+9,638
+46% +$75.5K
OPRT icon
2072
Oportun Financial
OPRT
$346M
$193K ﹤0.01%
9,306
-760
-8% -$13.9K
MRNS
2073
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$192K ﹤0.01%
12,435
+480
+4% +$6.94K
LQDT icon
2074
Liquidity Services
LQDT
$1.35B
$192K ﹤0.01%
10,346
+3,309
+47% +$59.9K
AMTB icon
2075
Amerant Bancorp
AMTB
$1.15B
$192K ﹤0.01%
10,329
-582
-5% -$9.72K

Similar funds

MetLife Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, MetLife Investment Management held 2,365 positions worth $10.9B, up 3.3% from $10.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $371M in Q1 2021, closing 53 positions and reducing 1,484 holdings. Its most notable exit was Plains All American Pipeline, an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, MetLife Investment Management opened a new position in NXP Semiconductors worth $13.3M.

  • MetLife Investment Management's largest Q1 2021 buy was NXP Semiconductors: 66,011 shares worth $13.3M.
  • MetLife Investment Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2021, an estimated $11.5M increase.
  • MetLife Investment Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $65.3M.
  • MetLife Investment Management fully exited Plains All American Pipeline in Q1 2021, selling an estimated $17.4M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $10.9B portfolio in Q1 2021.
  • MetLife Investment Management opened 95 new positions and closed 53 in Q1 2021.
  • MetLife Investment Management's portfolio value rose 3.3% quarter-over-quarter to $10.9B.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.